The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Open accessAbstract
Fibroblast growth factor (FGF) 23 inhibits renal phosphate reabsorption by activating FGF receptor (FGFR) 1c in a Klotho-dependent fashion. The phosphaturic activity of FGF23 is abrogated by proteolytic cleavage at the RXXR motif that lies at the boundary between the FGF core homology domain and the 72-residue-long C-terminal tail of FGF23. Here, we show that the soluble ectodomains of FGFR1c and Klotho are sufficient to form a ternary complex with FGF23 in vitro. The C-terminal tail of FGF23 mediates binding of FGF23 to a de novo site generated at the composite FGFR1c-Klotho interface. Consistent with this finding, the isolated 72-residue-long C-terminal tail of FGF23 impairs FGF23 signaling by competing with full-length ligand for binding to the binary FGFR-Klotho complex. Injection of the FGF23 C-terminal tail peptide into healthy rats inhibits renal phosphate excretion and induces hyperphosphatemia. In a mouse model of renal phosphate wasting attributable to high FGF23, the FGF23 C-terminal peptide reduces phosphate excretion, leading to an increase in serum phosphate concentration. Our data indicate that proteolytic cleavage at the RXXR motif abrogates FGF23 activity by a dual mechanism: by removing the binding site for the binary FGFR-Klotho complex that resides in the C-terminal region of FGF23, and by generating an endogenous inhibitor of FGF23. We propose that peptides derived from the C-terminal tail of FGF23 or peptidomimetics and small-molecule organomimetics of the C-terminal tail can be used as therapeutics to treat renal phosphate wasting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · cited 1×
“To exert its phosphaturic activity, FGF23 requires Klotho as an obligate coreceptor (20, 21), a protein first described as an aging suppressor (22).”
BackgroundSelf-citationSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Self-citationFrancis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Matsumura, Y., Aizawa, H., Shiraki-Iida, T., Nagai, R., Kuro-o, M., & Nabeshima, Y.-I. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8019 · Cited by 674
Self-citationGoetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02249-06 · Cited by 544
Self-citationImura, A., Iwano, A., Tohyama, O., Tsuji, Y., Nozaki, K., Hashimoto, N., Fujimori, T., & Nabeshima, Y.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.090 · Cited by 534
Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, Ö., Tenenhouse, H. S., Jüppner, H., & Jonsson, K. B. (2004) · Endocrinology · doi:10.1210/en.2003-1768 · Cited by 499
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
White, K. E., Carn, G., Lorenz-Depiereux, B., Benet-Pages, A., Strom, T. M., & Econs, M. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00064.x · Cited by 493
Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., & Nabeshima, Y.-I. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0048 · Cited by 491
Shimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.
Eicher, E. M., Southard, J. L., Scriver, C. R., & Glorieux, F. H. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4667 · Cited by 405
Immunohistochemical Localization of Klotho Protein in Brain, Kidney, and Reproductive Organs of Mice
Li, S.-A., Watanabe, M., Yamada, H., Nagai, A., Kinuta, M., & Takei, K. (2004) · Cell Structure and Function · doi:10.1247/csf.29.91 · Cited by 351
White, K. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.497 · Cited by 329
Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein1
Shiraki-Iida, T., Aizawa, H., Matsumura, Y., Sekine, S., Iida, A., Anazawa, H., Nagai, R., Kuro-o, M., & Nabeshima, Y.-I. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00127-6 · Cited by 308
Self-citationPerwad, F., Zhang, M. Y. H., Tenenhouse, H. S., & Portale, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00463.2006 · Cited by 300
Hypophosphatemia: An update on its etiology and treatment
Gaasbeek, A., & Meinders, A. E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.014 · Cited by 296
Beck, L., Soumounou, Y., Martel, J., Krishnamurthy, G., Gauthier, C., Goodyer, C. G., & Tenenhouse, H. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119276 · Cited by 290
Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia
Aono, Y., Yamazaki, Y., Yasutake, J., Kawata, T., Hasegawa, H., Urakawa, I., Fujita, T., Wada, M., Yamashita, T., Fukumoto, S., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090509 · Cited by 265
Jan de Beur, S. M. (2005) · JAMA · doi:10.1001/jama.294.10.1260 · Cited by 250
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Schouten, B. J., Hunt, P. J., Livesey, J. H., Frampton, C. M., & Soule, S. G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2396 · Cited by 235
Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
Farrow, E. G., Davis, S. I., Summers, L. J., & White, K. E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070783 · Cited by 232
A Novel Mutation in Fibroblast Growth Factor 23 Gene as a Cause of Tumoral Calcinosis
Araya, K., Fukumoto, S., Backenroth, R., Takeuchi, Y., Nakayama, K., Ito, N., Yoshii, N., Yamazaki, Y., Yamashita, T., Silver, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0301 · Cited by 222
Yamashita, T., Konishi, M., Miyake, A., Inui, K.-I., & Itoh, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202527200 · Cited by 217
Pex Gene Deletions in Gy and Hyp Mice Provide Mouse Models for X-Linked Hypophosphatemia
Strom, T. M., Francis, F., Lorenz, B., Boddrich, A., Lehrach, H., Econs, M. J., & Meitinger, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.165 · Cited by 199
Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23
Yamazaki, Y., Tamada, T., Kasai, N., Urakawa, I., Aono, Y., Hasegawa, H., Fujita, T., Kuroki, R., Yamashita, T., Fukumoto, S., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080417 · Cited by 195
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Bhan, I., Shah, A., Holmes, J., Isakova, T., Gutierrez, O., Burnett, S.-A., Jüppner, H., & Wolf, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001788 · Cited by 194
Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules
Baum, M. G., Schiavi, S. C., Dwarakanath, V. N., & Quigley, R. P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00506.x · Cited by 166
Establishment of the Anti-Klotho Monoclonal Antibodies and Detection of Klotho Protein in Kidneys
Kato, Y., Arakawa, E., Kinoshita, S., Shirai, A., Furuya, A., Yamano, K., Nakamura, K., Iida, A., Anazawa, H., Koh, N., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2009 · Cited by 159
Self-citationSegawa, H., Kawakami, E., Kaneko, I., Kuwahata, M., Ito, M., Kusano, K., Saitô, H., Fukushima, N., & Miyamoto, K. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1084-1 · Cited by 142
Hypophosphatemia: Clinical Consequences and Management
Brunelli, S. M., & Goldfarb, S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020143 · Cited by 117
Serum phosphate abnormalities in the emergency department
Shiber, J., & Mattu, A. (2002) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(02)00578-4 · Cited by 117
Nakatani, T., Ohnishi, M., & Razzaque, M. S. (2009) · The FASEB Journal · doi:10.1096/fj.08-123992 · Cited by 116
Self-citationFibroblast Growth Factor 23: Roles in Health and Disease
Imel, E. A., & Econs, M. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050573 · Cited by 110
Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling
van Boekel, G., Ruinemans‐Koerts, J., Joosten, F. B. M., Dijkhuizen, P. A., van Sorge, A., & de Boer, H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0779 · Cited by 61
Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis.
Garringer, H. J., Malekpour, M., Esteghamat, F., Mortazavi, S. M., Davis, S. I., Farrow, E., Yu, X.-J., Arking, D., Dietz, H., & White, K. (2008) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.90456.2008 · Cited by 58
Two novel GALNT3 mutations in familial tumoral calcinosis
Garringer, H. J., Mortazavi, S. M. J., Esteghamat, F., Malekpour, M., Boztepe, H., Tanakol, R., Davis, S. I., & White, K. E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31947 · Cited by 49
Hereditary hypophosphatemias: New genes in the bone–kidney axis (Review Article)
Negri, A. L. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00824.x · Cited by 12
Cited by
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C., Kuro-o, M., & Moe, O. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 926
Self-citationFGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Hu, M. C., Shiizaki, K., Kuro-o, M., & Moe, O. W. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183727 · Cited by 587
Self-citationKlotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Razzaque, M. S., Rosenblatt, K. P., Baum, M. G., Kuro‐O, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154765 · Cited by 578
Self-citationExploring mechanisms of FGF signalling through the lens of structural biology
Goetz, R., & Mohammadi, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3528 · Cited by 573
Self-citation
Metadata
- Authors
- Goetz, R., Nakada, Y., Hu, M. C., Kurosu, H., Wang, L., Nakatani, T., Shi, M., Eliseenkova, A. V., Razzaque, M. S., Moe, O. W., Kuro-o, M., & Mohammadi, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-12-29
- Volume
- 107
- Issue
- 1
- Pages
- 407-412
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025952915
- Cited by
- 381
- References
- 43
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.